IRESF:OTC-iShares Public Limited Company - iShares Core FTSE 100 UCITS ETF (USD)

ETF | Others |

Last Closing

USD 7.29

Change

-0.01 (-0.14)%

Market Cap

N/A

Volume

3.15K

Analyst Target

N/A
Analyst Rating

N/A

ducovest Verdict

Verdict

About

Unadjusted Closing Price

Adjusted Closing Price

Share Volume

Relative Performance (Total Returns)

Compare
Relative Returns (From:    To: 2024-07-02 )

Largest Industry Peers for Others

Symbol Name Price(Change) Market Cap
CSTNL iShares VII Public Limited Com..

+3.90 (+0.67%)

USD 32.85B
JDEPY JDEPY

+0.70 (+6.25%)

USD 9.92B
IISHF iShares III Public Limited Com..

N/A

USD 9.10B
ZKBGF ZKB Gold ETF

N/A

USD 8.96B
IHPCF iShares Public Limited Company..

N/A

USD 8.93B
TOETF Tosei Corporation

N/A

USD 7.70B
CUYTY Etablissementen Franz Colruyt ..

N/A

USD 7.56B
EFMSF ETFS Metal Securities Limited ..

N/A

USD 7.39B
BCYIF iShares Public Limited Company..

N/A

USD 5.80B
IIREF iShares Public Limited Company..

N/A

USD 5.32B

ETFs Containing IRESF

N/A

Market Performance

  Market Performance vs. Industry/Classification (Others) Market Performance vs. Exchange
  Value Sector Median Percentile Rank Grade Market Median Percentile Rank Grade
YTD  
Capital Gain 6.80% 58% F 63% D
Dividend Return N/A N/A N/A N/A N/A
Total Return 6.80% 58% F 62% D
Trailing 12 Months  
Capital Gain 12.80% 61% D- 71% C-
Dividend Return N/A N/A N/A N/A N/A
Total Return 12.80% 60% D- 69% C-
Trailing 5 Years  
Capital Gain N/A N/A N/A N/A N/A
Dividend Return N/A N/A N/A N/A N/A
Total Return N/A N/A N/A N/A N/A
Average Annual (5 Year Horizon)  
Capital Gain 9.23% 66% D+ 54% F
Dividend Return 9.23% 66% D+ 50% F
Total Return N/A N/A N/A N/A N/A
Risk Return Profile  
Volatility (Standard Deviation) 10.30% 70% C- 96% N/A
Risk Adjusted Return 89.61% 98% N/A 98% N/A
Market Capitalization N/A N/A N/A N/A N/A

Annual Financials (USD)

Quarterly Financials (USD)

Analyst Rating

Target Price Action Rating Action Analyst Rating Price Date

This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.

What to like:
Superior risk adjusted returns

This stock has performed well, on a risk adjusted basis, compared to its sector peers(for a hold period of at least 12 months) and is in the top quartile.

What to not like:

There is nothing we particularly dislike